Navigation Links
SOCMA President to Lead ChemOutsourcing Keynote Panel on API Supply Base on Wednesday, September 15 at New Jersey Show
Date:9/13/2010

LONG BRANCH, N.J., Sept. 13 /PRNewswire/ -- SOCMA President & CEO Lawrence Sloan will lead the keynote panel discussion at the annual ChemOutsourcing conference this coming Wednesday morning. The panel will address the "Shifting Landscape of the API Supply Base" to explore the evolving API supply chain, reports Mark Alexay, the organizer.

Sloan's opening remarks will touch on current global supply chain topics and SOCMA's Bulk Drug Pharmaceutical Task Force. The BPTF was set up to address supply chain concerns and provide information to the FDA and Congress on related issues. The discussion will then be opened up to the speakers.

The panel discussion is organized around the following topics:

  • Legislative & Regulatory Activity
  • Strategies to Better Safeguard API Sourcing
  • Future of API Sourcing

  • The panel is comprised of the following participants:M. Bhupathy, Ph.D.Executive Director, Chemistry R & D OutsourcingAmgen Michael EakinsPrincipal ConsultantEakins & Associates Elut HsuVP Business DevelopmentAsymchem LaboratoriesNeil SawantAssociate Director, Development Strategic SourcingNovartis Michael SemoConsultant, Virtual CMC TeamEli Lilly Stuart SilvermanPharmaceutical Business DevelopmentPfizerPress and other contacts may reach ChemOutsourcing organizer Mark Alexay at info@chemoutsourcing.com, 201 452 4023

    ChemOutsourcing is an annual chemical sourcing and ingredients conference & exhibition focused on the pharmaceutical, small molecule biotech, and chemical industries. It takes places in September in New Jersey. The international event is attended primarily by 750-1000 industrial chemists. ChemOutsourcing 2010 will take place from September 13-16 at Ocean Place Resort in Long Branch, NJ. Additional information is available at www.chemoutsourcing.com.


    '/>"/>
    SOURCE ChemOutsourcing
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1

    Related biology technology :

    1. Medicago named in Presidential report on meeting the challenges of pandemic influenza
    2. PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
    3. Verenium Appoints Kevin Bracken Vice President of Manufacturing
    4. Scott & White Healthcare President and CEO Alfred B. Knight, M.D. to Retire in 2011, Will Lead Foundation
    5. Sigma-Aldrich Announces Appointment of Magnus Borg as Vice President and Chief Information Officer (CIO)
    6. Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
    7. Chimerix Appoints Two New Vice Presidents to Clinical Management Team
    8. SemBioSys Appoints President of US and International Operations and Announces the Appointments of Three Vice Presidents
    9. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
    10. Michael Garippa Joins SynCardia as President
    11. New President and CEO appointed at Ocean Nutrition Canada Limited
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/17/2017)... February 17, 2017 According ... by Product (Consumables, Service), Type (Safety, Efficacy, Validation), ... Drug Discovery and Development, Disease-Risk) - Global Forecast ... projected to reach USD 53.34 Billion by 2021 ... a CAGR of 13.8% during the forecast period ...
    (Date:2/17/2017)... Feb. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... its oral peptide drug candidates, PTG-100 and PTG-200, ... European Crohn,s and Colitis Organization (ECCO).  The ECCO ... Spain from February 15 – 18, ... data on Protagonist drug candidates PTG-100 and PTG-200. ...
    (Date:2/16/2017)... and GREENWICH, Conn. ... private investment firm focused on venture growth investments ... promotion of Josh Richardson , M.D. to ... investments in biotechnology companies.  He is a board ... important roles in Longitude,s investments in Aimmune Therapeutics, ...
    (Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
    Breaking Biology Technology:
    (Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
    (Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
    (Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
    Breaking Biology News(10 mins):